Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058051HIVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20057150HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20057354HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20040604HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS44006680HTLV-1ENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TCGA Plot Options
Drug Information
GeneDRD3
DrugBank IDDB00409
Drug NameRemoxipride
Target IDBE0000581
UniProt IDP35462
Regulation Typeantagonist
PubMed IDs11325388; 8405075
CitationsChristian AJ, Goodwin AK, Baker LE: Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A. Pharmacol Biochem Behav. 2001 Mar;68(3):371-7.@@Mohell N, Sallemark M, Rosqvist S, Malmberg A, Hogberg T, Jackson DM: Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors. Eur J Pharmacol. 1993 Jul 6;238(1):121-5. doi: 10.1016/0014-2999(93)90515-j.
GroupsApproved; Withdrawn
Direct ClassificationDimethoxybenzenes
SMILESCCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC
Pathways
PharmGKBPA164749051
ChEMBLCHEMBL22242